Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04120584 · ClinicalTrials.gov registry record · NA

Radio Frequency (Forma Eye) Treatment for Dry Eye Disease Due to Meibomian Gland Dysfunction

A NA study, sponsored by InMode MD.

Completed
Registry status
NA
Development phase
47
Enrollment target

NCT04120584 is a NA study that has completed, run by InMode MD. The registered enrollment target is 47 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04120584, a NA study, has completed, sponsored by InMode MD.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target

Study Summary

The aim of the study is to evaluate the safety and efficacy of radiofrequency treatment for dry eye disease due to meibomian gland dysfunction

Interventions

  • DEVICE Forma Eye Applicator

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2019-10-22
Est. Completion 2022-07-25
Phase NA

Sponsor

InMode MD

22 total trials

What the Registry Record Tells You About NCT04120584

The ClinicalTrials.gov registry entry for NCT04120584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InMode MD, which has 22 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Forma Eye Applicator is the first listed.

NCT04120584 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04120584 about?

NCT04120584 is a clinical study titled "Radio Frequency (Forma Eye) Treatment for Dry Eye Disease Due to Meibomian Gland Dysfunction". The aim of the study is to evaluate the safety and efficacy of radiofrequency treatment for dry eye disease due to meibomian gland dysfunction

What is the current status of trial NCT04120584?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2019-10-22. Estimated completion is 2022-07-25.

What interventions are being tested in trial NCT04120584?

The interventions under investigation include: Forma Eye Applicator (DEVICE).

Who is sponsoring clinical trial NCT04120584?

This trial is sponsored by InMode MD, which has 22 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.